Multivalent RNA nanoparticles for delivery of active agents to a cell

Details for Australian Patent Application No. 2006275579 (hide)

Owner Purdue Research Foundation

Inventors Guo, Peixuan

Agent Wynnes Patent & Trade Mark Attorneys

Pub. Number AU-B-2006275579

PCT Pub. Number WO2007/016507

Priority 60/704,261 01.08.05 US

Filing date 1 August 2006

Wipo publication date 8 February 2007

Acceptance publication date 4 October 2012

International Classifications

C12N 15/113 Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

C07H 21/02 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 Mutation or genetic engineering - DNA or RNA fragments

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

21 February 2008 PCT application entered the National Phase

  PCT publication WO2007/016507 Priority application(s): WO2007/016507

4 October 2012 Application Accepted

  Published as AU-B-2006275579

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006275580-Insertable thermotic module for selfheating can

2006275575-Insurance products and related methods and systems